We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,406
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LILM
13101
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$8.35K ﹤0.01%
11,706
+8,521
+268% +$9.96K
GCTK icon
13102
GlucoTrack
GCTK
$2.84M
$8.34K ﹤0.01%
+5
New +$8.98K
ETON icon
13103
PUT
Eton Pharmaceutcials
ETON
$1.61B
$8.34K ﹤0.01%
2,000
+900
+82% +$3.47K
APYX icon
13104
CALL
Apyx Medical
APYX
$128M
$8.32K ﹤0.01%
2,600
-18,800
-88% -$87.6K
APYX icon
13105
PUT
Apyx Medical
APYX
$128M
$8.32K ﹤0.01%
2,600
+700
+37% +$3.26K
MBIN icon
13106
CALL
Merchants Bancorp
MBIN
$2.52B
$8.32K ﹤0.01%
300
+100
+50% +$2.89K
VBIV
13107
CALL
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$8.3K ﹤0.01%
+12,458
New +$15.3K
QBTS icon
13108
PUT
D-Wave Quantum Inc
QBTS
$7.88B
$8.3K ﹤0.01%
8,600
-16,300
-65% -$26K
RNAM
13109
PUT
DELISTED
Avidity Biosciences
RNAM
$8.29K ﹤0.01%
1,300
-17,300
-93% -$149K
ARKX icon
13110
CALL
ARK Space & Defense Innovation ETF
ARKX
$865M
$8.27K ﹤0.01%
600
-6,400
-91% -$93.5K
HOOK
13111
CALL
DELISTED
HOOKIPA Pharma
HOOK
$8.25K ﹤0.01%
1,340
UPH
13112
DELISTED
UpHealth, Inc.
UPH
$8.25K ﹤0.01%
+8,416
New +$12.3K
WNW icon
13113
Meiwu Technology Co
WNW
$67.4M
$8.24K ﹤0.01%
+1
New +$10.8K
IMMP
13114
Immutep
IMMP
$56M
$8.23K ﹤0.01%
4,332
-4,190
-49% -$8.5K
KB icon
13115
CALL
KB Financial Group
KB
$42.1B
$8.22K ﹤0.01%
200
-22,000
-99% -$872K
WWR icon
13116
PUT
Westwater Resources
WWR
$72.7M
$8.21K ﹤0.01%
12,300
+100
+0.8% +$76
FTK icon
13117
CALL
Flotek Industries
FTK
$1.3B
$8.21K ﹤0.01%
1,853
+586
+46% +$2.78K
ATXS
13118
PUT
DELISTED
Astria Therapeutics
ATXS
$8.21K ﹤0.01%
1,100
-4,400
-80% -$37.5K
NTWK icon
13119
CALL
NetSol Technologies
NTWK
$48.3M
$8.19K ﹤0.01%
4,500
+1,900
+73% +$4.24K
SSL icon
13120
Sasol
SSL
$7.39B
$8.19K ﹤0.01%
599
-43,742
-99% -$574K
HGTY icon
13121
PUT
Hagerty
HGTY
$1.32B
$8.17K ﹤0.01%
1,000
+900
+900% +$7.89K
DSI icon
13122
PUT
iShares MSCI KLD 400 Social ETF
DSI
$5.58B
$8.14K ﹤0.01%
+100
New +$8.48K
HBIO icon
13123
Harvard Bioscience
HBIO
$30.3M
$8.13K ﹤0.01%
189
-188
-50% -$8.68K
SLGC
13124
PUT
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$8.13K ﹤0.01%
3,400
-3,300
-49% -$7.31K
CGRN
13125
CALL
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$8.08K ﹤0.01%
11,400

Similar funds

Citadel Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Citadel Advisors held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Citadel Advisors's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Citadel Advisors's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Citadel Advisors added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Citadel Advisors's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Citadel Advisors fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Citadel Advisors's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Citadel Advisors opened 1,406 new positions and closed 1,460 in Q3 2023.
  • Citadel Advisors's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.